Entrada Therapeutics

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$1,614
$1,950
$20,558
$37,398
Gross Profit
-36,747
1,950
20,558
37,398
EBITDA
-42,250
-45,815
-20,844
-4,875
EBIT
-43,480
-46,849
-21,790
-5,867
Net Income
-44,134
-43,103
-17,349
1,131
Net Change In Cash
1,614
1,950
20,558
37,398
Free Cash Flow
-28,142
-29,764
-39,651
-32,240
Cash
93,286
72,482
67,837
101,211
Basic Shares
41,462
41,339
41,074
43,050

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$210,782
$129,013
$25,260
$0
Gross Profit
210,782
129,013
-1,895
-1,117
EBITDA
50,784
-321
-95,353
-50,010
EBIT
47,011
-3,162
-97,248
-51,127
Net Income
65,626
-6,685
-87,457
-50,072
Net Change In Cash
210,782
129,013
25,260
0
Cost of Revenue
252,019
Free Cash Flow
-44,715
134,189
-96,673
-55,442
Cash
101,211
67,602
45,157
291,064
Basic Shares
39,003
33,050
31,293
31,224

Earnings Calls

QuarterEPS
2025-09-30
-$1.06
2025-06-30
-$1.04
2025-03-31
-$0.42
2024-12-31
$0.03